ANTSO are manufacturing a new non-invasive therapy for non-melanoma skin cancer patients, providing treatment without surgery.
The therapy is useful for skin cancers around 3 millimetres in depth and is applied only to the area requiring treatment, sparing healthy tissue.
The treatment is currently in clinical trial with the data so far showing positive cosmetic outcome, according to ANTSO General Manager of Business Development and Commercialisation Rosanne Robinson.
